Clinical profile of PiB-positive corticobasal syndrome.

BACKGROUND: Corticobasal syndrome (CBS) is a multifaceted neurodegenerative disorder characterized by a combination of motor and cognitive deficits. Several different pathological entities, including Alzheimer's pathology, have been described in association with CBS. The present study aimed to...

Full description

Bibliographic Details
Main Authors: James R Burrell, Michael Hornberger, Victor L Villemagne, Christopher C Rowe, John R Hodges
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3618463?pdf=render
id doaj-8ec7f6a5d5e84ded849da26c825da3b4
record_format Article
spelling doaj-8ec7f6a5d5e84ded849da26c825da3b42020-11-25T02:42:36ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0184e6102510.1371/journal.pone.0061025Clinical profile of PiB-positive corticobasal syndrome.James R BurrellMichael HornbergerVictor L VillemagneChristopher C RoweJohn R HodgesBACKGROUND: Corticobasal syndrome (CBS) is a multifaceted neurodegenerative disorder characterized by a combination of motor and cognitive deficits. Several different pathological entities, including Alzheimer's pathology, have been described in association with CBS. The present study aimed to establish clinical, neuropsychological, and neuroimaging features that could be useful in the distinction of CBS due to AD pathology from other CBS cases in life based on [(11)C] Pittsburgh Compound B positron emission tomography (PiB-PET) status. METHODS: Patients with CBS were prospectively recruited from a specialized cognitive disorders clinic. All patients underwent detailed clinical and neuropsychological assessment, with structural imaging using voxel-based analysis of magnetic resonance imaging. Alzheimer's pathology was detected using PiB-PET imaging, and PiB-positive and PiB-negative groups were compared. RESULTS: Fourteen CBS patients meeting defined criteria were included (7 male, 7 female; mean age 66.1+/-6.9 years; median symptom duration was 35.5+/-22.6 months) and compared to 20 matched control subjects. Of the 14 patients, 4 were PiB-positive and 10 PiB-negative. There were no significant differences between PiB-positive and PiB-negative CBS patients in age, gender, education, symptom duration, or motor features. PiB-positive patients had greater visuospatial deficits, a higher rate of sentence repetition impairment, and more functional decline. Voxel-based morphometry analyses demonstrated extensive peri-insular and post-central atrophy in both groups, but PiB-positive patients had atrophy that extended to include the posterior part of the left superior temporal gyrus. CONCLUSIONS: Visuospatial function, aspects of language, and the pattern of cerebral atrophy may be useful in distinguishing patients with CBS due to underlying AD pathology.http://europepmc.org/articles/PMC3618463?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author James R Burrell
Michael Hornberger
Victor L Villemagne
Christopher C Rowe
John R Hodges
spellingShingle James R Burrell
Michael Hornberger
Victor L Villemagne
Christopher C Rowe
John R Hodges
Clinical profile of PiB-positive corticobasal syndrome.
PLoS ONE
author_facet James R Burrell
Michael Hornberger
Victor L Villemagne
Christopher C Rowe
John R Hodges
author_sort James R Burrell
title Clinical profile of PiB-positive corticobasal syndrome.
title_short Clinical profile of PiB-positive corticobasal syndrome.
title_full Clinical profile of PiB-positive corticobasal syndrome.
title_fullStr Clinical profile of PiB-positive corticobasal syndrome.
title_full_unstemmed Clinical profile of PiB-positive corticobasal syndrome.
title_sort clinical profile of pib-positive corticobasal syndrome.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2013-01-01
description BACKGROUND: Corticobasal syndrome (CBS) is a multifaceted neurodegenerative disorder characterized by a combination of motor and cognitive deficits. Several different pathological entities, including Alzheimer's pathology, have been described in association with CBS. The present study aimed to establish clinical, neuropsychological, and neuroimaging features that could be useful in the distinction of CBS due to AD pathology from other CBS cases in life based on [(11)C] Pittsburgh Compound B positron emission tomography (PiB-PET) status. METHODS: Patients with CBS were prospectively recruited from a specialized cognitive disorders clinic. All patients underwent detailed clinical and neuropsychological assessment, with structural imaging using voxel-based analysis of magnetic resonance imaging. Alzheimer's pathology was detected using PiB-PET imaging, and PiB-positive and PiB-negative groups were compared. RESULTS: Fourteen CBS patients meeting defined criteria were included (7 male, 7 female; mean age 66.1+/-6.9 years; median symptom duration was 35.5+/-22.6 months) and compared to 20 matched control subjects. Of the 14 patients, 4 were PiB-positive and 10 PiB-negative. There were no significant differences between PiB-positive and PiB-negative CBS patients in age, gender, education, symptom duration, or motor features. PiB-positive patients had greater visuospatial deficits, a higher rate of sentence repetition impairment, and more functional decline. Voxel-based morphometry analyses demonstrated extensive peri-insular and post-central atrophy in both groups, but PiB-positive patients had atrophy that extended to include the posterior part of the left superior temporal gyrus. CONCLUSIONS: Visuospatial function, aspects of language, and the pattern of cerebral atrophy may be useful in distinguishing patients with CBS due to underlying AD pathology.
url http://europepmc.org/articles/PMC3618463?pdf=render
work_keys_str_mv AT jamesrburrell clinicalprofileofpibpositivecorticobasalsyndrome
AT michaelhornberger clinicalprofileofpibpositivecorticobasalsyndrome
AT victorlvillemagne clinicalprofileofpibpositivecorticobasalsyndrome
AT christophercrowe clinicalprofileofpibpositivecorticobasalsyndrome
AT johnrhodges clinicalprofileofpibpositivecorticobasalsyndrome
_version_ 1724772690640764928